New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

The study observed comparable responses in both groups, except for heightened sensitivity to low-dose glucagon among individuals with diabetes. Moreover, recent episodes of hypoglycemia did not ...

The dosage for bupropion varies depending on the ... You can take bupropion XL or bupropion SR tablets with or without food. Do not crush, chew, or cut these tablets, as this can affect how ...

Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of prescribing glucagon, positioning the partners to address a fundamental ...

The two organizations will work together on a campaign to raise awareness about the importance of glucagon. According to the ADA, nearly half of all people with type 1 diabetes suffer from at least ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling out new data on a higher-dose injection in obesity. In the phase 3b ...

Glucagon prescriptions for severe hypoglycemia in Medicaid initially decreased from 2012 to 2018 but increased between 2019 and 2023 following the introduction of newer products. Glucagon ...

Consumer Reports has no financial relationship with any advertisers on this site. For decades, taking low-dose aspirin (81 mg) every day was widely recommended as an easy way to prevent heart ...

It’s important to take the clonidine dosage your doctor prescribes ... doctors prescribe a drug for a purpose other than what the Food and Drug Administration (FDA) approved it for.